Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Bupaq
|
Active substances:
|
|
ATC code:
|
QN02AE01
|
Dosage form:
|
solution for injection
|
Strength:
|
0,3mg 1ml
|
Legal status for supply*:
|
Prescription for narcotic drugs
|
Summary of product characteristics (SPC):
|
(last updated February 27, 2023)
|
Package information leaflet (PIL):
|
EST (last updated June 26, 2023)
|
Labelling:
|
(last updated February 27, 2023)
|
Indication:
|
DOG
Post-operative analgesia.
Potentiation of the sedative effects of centrally-acting agents.
CAT
Post-operative analgesia.
|
Safety features:
|
No
|
Marketing authorization holder:
|
Vetviva Richter GmbH
|
Marketing authorization number:
|
2112
|
Marketing authorization issued on:
|
September 5, 2018
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Mutual recognition
|
Assessment report:
|
(last updated September 5, 2018)
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1766796
|
Bupaq
|
solution for injection
|
0,3mg 1ml 2ml 3TK
|
N
|
|
|
|
|
|
1766808
|
Bupaq
|
solution for injection
|
0,3mg 1ml 2ml 4TK
|
N
|
|
|
|
|
|
1766819
|
Bupaq
|
solution for injection
|
0,3mg 1ml 2ml 5TK
|
N
|
|
|
|
|
|
1766820
|
Bupaq
|
solution for injection
|
0,3mg 1ml 2ml 6TK
|
N
|
|
|
12.10.2020
|
|
|
1766831
|
Bupaq
|
solution for injection
|
0,3mg 1ml 2ml 10TK
|
N
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere